Skip to content

Study to estimate the efficacy of reduced form of coenzyme Q10 (ubiquinol) for maintaining good health in healthy paersons.

Study to estimate the efficacy of reduced form of coenzyme Q10 (ubiquinol) for maintaining good health in healthy paersons by open labbeled test. - Ubiquinol efficacy for maintaining good health.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041872
Enrollment
500
Registered
2020-09-30
Start date
2020-08-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

reduced form of coenzyme Q10 ( ubiquinol), 100mg/day, two years

Sponsors

Kaneka Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Empolyee of Kaneka Corporation (2) Possible to join the regularly health check. (3) Over 18 years old.

Exclusion criteria

Exclusion criteria: (1) Persons who have allegy to ubiquinol. (2) Under medication or take supplement which has same efficacy of ubiquinol. (3) Patience of cancser or such seruous disease. (4) Doctor did not allow to entry to this study.

Design outcomes

Primary

MeasureTime frame
QOL (fatigue, stress, sleep)

Countries

Japan

Contacts

Public ContactTetsu Kinoshita

Institute of Community Life Sciences Co., Ltd. Social Epidemiology Institute

tetsu@shin-science.co.jp089-904-7811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026